Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Global 2-year trial reports on CAR-T therapy to treat DLBCL

europeanpharmaceuticalreviewDecember 04, 2018

Tag: Cancer , DLBCL , CAR-T therapy

PharmaSources Customer Service